CSI Market
Sign In | Register

Pharming Group N v (PHAR) Annual Balance Sheets

Annual · GAAP · USD millions
Access PHAR quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Pharming Group N v's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash And Cash Equivalents145.31
Cash & Short-term Investments145.00
Accounts receivable41.77
Trade & Other Current Receivables (IFRS combined total)54.70
Inventories64.90
Other Current Assets89.26
Total Current Assets299.47
Equipment/Property/Plant Net7.23
Intangible Assets135.54
Tax Assets, Noncurrent41.50
Other Assets, Noncurrent135.54
Trade And Other Current Receivables54.70
Current Restricted Cash And Cash Equivalents0.76
Deferred Tax Liability Asset-
Investments In Associates Accounted For Using Equity Method1.94
Noncurrent Financial Assets At Fair Value Through Profit Or Loss6.70
Noncurrent Restricted Cash And Cash Equivalents1.23
Noncurrent Assets200.50
Total Assets499.96
Liabilities
Accounts Payable105.90
Other Liabilities, Current115.79
Total Current Liabilities115.79
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent10.48
Other liabilities, Noncurrent0.00
Total Liabilities126.27
Stockholders' Equity
Other Equity277.42
Common Stockholder's Equity277.42
Total Stockholder's Equity277.10
Liabilities & Stockholder's Equity499.96
4 historic quarters locked

Sign in to unlock the full Pharming Group N v balance sheet history.

Sign In Create Free Account

About Pharming Group N V Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001828316-26-000015

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License